Deep Genomics
PrivateLast Round
Series C
Jul 28, 2021
Total Funding Raised
$236.7M
Company Overview
Deep Genomics is a biotechnology company that operates an AI-driven platform for genetic medicine discovery, aimed at transforming drug development by utilizing AI to unravel RNA biology and identify novel therapeutic targets and mechanisms.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Data as a Service
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Deep Genomics Comparables
Compare Deep Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Envisagenics | 88% | |
| Inceptive | 85% | |
| Creyon Bio | 85% | |
Deep Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 28, 2021 | ||||
| Series B | Jan 7, 2020 | ||||
| Series A | Sep 25, 2017 | ||||
| Seed | Nov 18, 2015 |
Key People
Founding team and executive leadership
Deep Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series A |
| Magnetic Ventures | Series C, Series B |
| CPP Investments | Series C |
| Horizons Ventures | Series C |
| SoftBank Investment Advisers | Series C |
| Future Ventures | Series B |
| NJF Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 6, 2025
Paul Sekhri appointed to the Board of Directors.
- Oct 6, 2025
Thong Q. Le has been appointed to the Board of Directors.
Deep Genomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Deep Genomics's valuation, stock price, and market status.